Results 241 to 250 of about 25,888 (267)
Some of the next articles are maybe not open access.
Methods and Findings in Experimental and Clinical Pharmacology, 2010
The anxiolytic-like effects of selective serotonin reuptake inhibitors (SSRIs; paroxetine, fluvoxamine) and serotonin-noradrenaline reuptake inhibitors (SNRIs; milnacipran, venlafaxine) were compared with those of benzodiazepines (diazepam, chlordiazepoxide) and tricyclic antidepressants (imipramine, amitriptyline) using the elevated plus maze in mice.
T, Takeuchi +3 more
openaire +2 more sources
The anxiolytic-like effects of selective serotonin reuptake inhibitors (SSRIs; paroxetine, fluvoxamine) and serotonin-noradrenaline reuptake inhibitors (SNRIs; milnacipran, venlafaxine) were compared with those of benzodiazepines (diazepam, chlordiazepoxide) and tricyclic antidepressants (imipramine, amitriptyline) using the elevated plus maze in mice.
T, Takeuchi +3 more
openaire +2 more sources
Life Sciences, 2001
The effects of venlafaxine, a novel serotonin and adrenaline reuptake inhibitor, on the morphine withdrawal and activation of morphine conditioned place preference (CPP), were investigated in rats. Our results showed that the most morphine withdrawal signs, including jumping, writhing, shakes, exploring, lacrimation, piloerection, irritability, and ...
L, Lu +6 more
openaire +2 more sources
The effects of venlafaxine, a novel serotonin and adrenaline reuptake inhibitor, on the morphine withdrawal and activation of morphine conditioned place preference (CPP), were investigated in rats. Our results showed that the most morphine withdrawal signs, including jumping, writhing, shakes, exploring, lacrimation, piloerection, irritability, and ...
L, Lu +6 more
openaire +2 more sources
Australasian Psychiatry, 2018
Objective: Milnacipran is a serotonin noradrenaline reuptake inhibitor (SNRI) approved for treatment of fibromyalgia in Australia, but is used for depression in Europe and elsewhere. This paper will briefly review milnacipran and its utility in psychiatry for the treatment of depression.
Nicholas A, Keks +3 more
openaire +2 more sources
Objective: Milnacipran is a serotonin noradrenaline reuptake inhibitor (SNRI) approved for treatment of fibromyalgia in Australia, but is used for depression in Europe and elsewhere. This paper will briefly review milnacipran and its utility in psychiatry for the treatment of depression.
Nicholas A, Keks +3 more
openaire +2 more sources
International Clinical Psychopharmacology, 2002
Depression is common after stroke. While several reports have been published on the use of antidepressants such as selective serotonin reuptake inhibitors and tricyclics for the treatment of post-stroke depression (PSD), no previous study has examined the use of a selective serotonin and noradrenaline reuptake inhibitor (SNRI) for this condition.
M, Kimura +5 more
openaire +2 more sources
Depression is common after stroke. While several reports have been published on the use of antidepressants such as selective serotonin reuptake inhibitors and tricyclics for the treatment of post-stroke depression (PSD), no previous study has examined the use of a selective serotonin and noradrenaline reuptake inhibitor (SNRI) for this condition.
M, Kimura +5 more
openaire +2 more sources
Pharmacological Reports, 2012
Although several studies show that there is an increased risk of bleeding events during antidepressant treatment with selective serotonin reuptake inhibitors (SSRIs), few studies show direct effects in vitro of SSRIs on hemostasis.This study was undertaken to investigate the effects on platelet adhesion and plasma coagulation (APTT and PT) of two ...
Ida, Hallbäck +3 more
openaire +2 more sources
Although several studies show that there is an increased risk of bleeding events during antidepressant treatment with selective serotonin reuptake inhibitors (SSRIs), few studies show direct effects in vitro of SSRIs on hemostasis.This study was undertaken to investigate the effects on platelet adhesion and plasma coagulation (APTT and PT) of two ...
Ida, Hallbäck +3 more
openaire +2 more sources
[Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
Nihon rinsho. Japanese journal of clinical medicine, 2001Pharmacology, clinical efficacy and tolerability of serotonin noradrenaline reuptake inhibitors(SNRIs) are overviewed. They include milnacipran, venlafaxine, duloxetine, MCI-225 and nefazodone, however, only milnacipran is currently used in Japan.
openaire +1 more source
Human Psychopharmacology: Clinical and Experimental, 2015
ObjectiveThe present study provides a comprehensive review of the existing literature on the safety of serotonin–noradrenaline reuptake inhibitors (SNRIs) in pregnancy and lactation.MethodsStudies published in English, reporting the use of SNRIs in pregnant and/or breastfeeding women, were identified by searching MEDLINE/Pubmed, PsycINFO, and EMBASE ...
Bellantuono C +4 more
openaire +3 more sources
ObjectiveThe present study provides a comprehensive review of the existing literature on the safety of serotonin–noradrenaline reuptake inhibitors (SNRIs) in pregnancy and lactation.MethodsStudies published in English, reporting the use of SNRIs in pregnant and/or breastfeeding women, were identified by searching MEDLINE/Pubmed, PsycINFO, and EMBASE ...
Bellantuono C +4 more
openaire +3 more sources
Heart, Lung and Circulation, 2012
Tako-Tsubo cardiomyopathy (TTC) occurs particularly in post-menopausal women, being precipitated in many cases by severe emotional stress. We describe six patients in whom TTC occurred in association with therapeutic ingestion or overdose of the serotonin/noradrenaline reuptake inhibitor venlafaxine, or its metabolite desvenlafaxine.
Neil, C. +3 more
openaire +3 more sources
Tako-Tsubo cardiomyopathy (TTC) occurs particularly in post-menopausal women, being precipitated in many cases by severe emotional stress. We describe six patients in whom TTC occurred in association with therapeutic ingestion or overdose of the serotonin/noradrenaline reuptake inhibitor venlafaxine, or its metabolite desvenlafaxine.
Neil, C. +3 more
openaire +3 more sources
Serotonin noradrenaline reuptake inhibitors: A new generation of treatment for anxiety disorders
International Journal of Psychiatry in Clinical Practice, 2006A variety of agents are currently used to treat the different anxiety disorders. Benzodiazepines, such as diazepam, are still preferred by some for the treatment of acute anxiety, with the advantage of a rapid onset of action, but they are less suitable for long-term treatment due to their potential for memory disturbances, sleepiness, lethargy ...
openaire +3 more sources
Treatment of erythromelalgia with a serotonin/noradrenaline reuptake inhibitor
British Journal of Dermatology, 2002A, Moiin +3 more
openaire +2 more sources